NCT06395155

A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Drug-drug Interactions Between DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Daehwa Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This phase 1 study is to evaluate the safety and pharmacokinetic drug interactions of DHP2306R1 and DHP2306R2 when administered alone and in combination in healthy conditions. Participants will be taken DHP2306R1 and DHP2306R2 alone or combination for 3 period, randomized in six-sequence.

Conditions

• Musculoskeletal Pain

Interventions

Type	Name	Description
DRUG	DHP2306R1	100mg per capsule, BID
DRUG	DHP2306R2	75mg per Tab, BID

Timeline

• Start date: 2023-10-26
• Primary completion: 2023-12-07
• Completion: 2023-12-07
• First posted: 2024-05-02
• Last updated: 2024-07-25

Locations

1 site across 1 country: South Korea